Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines

IMPORTANCE: In April 2021, the US Department of Health and Human Services (HHS) released practice guidelines exempting educational requirements to obtain a Drug Addiction Treatment Act (DATA) waiver to treat up to 30 patients with opioid use disorder with buprenorphine. OBJECTIVE: To compare demogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christopher M., Olsen, Yngvild, Ali, Mir M., Sherry, Tisamarie B., Mcaninch, Jana, Creedon, Timothy, Juliana, Patti, Jacobus-Kantor, Laura, Baillieu, Robert, Diallo, Mamadou Misbaou, Thomas, Anita, Gandotra, Neeraj, Sokolowska, Marta, Ling, Shari, Compton, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362471/
https://www.ncbi.nlm.nih.gov/pubmed/37477926
http://dx.doi.org/10.1001/jamahealthforum.2023.1982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362471/
https://www.ncbi.nlm.nih.gov/pubmed/37477926
http://dx.doi.org/10.1001/jamahealthforum.2023.1982

Ejemplares similares